Brett Sandercock
2021
In 2021, Brett Sandercock earned a total compensation of $3M as Chief financial officer at ResMed, a 4% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $464,318 |
|---|---|
| Salary | $494,225 |
| Stock Awards | $2,000,000 |
| Other | $55,683 |
| Total | $3,014,226 |
Sandercock received $2M in stock awards, accounting for 66% of the total pay in 2021.
Sandercock also received $464.3K in non-equity incentive plan, $494.2K in salary and $55.7K in other compensation.
Rankings
In 2021, Brett Sandercock's compensation ranked 4,412th out of 12,397 executives tracked by ExecPay. In other words, Sandercock earned more than 64.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,412 out of 12,397 | 64th |
Division Manufacturing | 1,815 out of 5,492 | 67th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 228 out of 798 | 71st |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 141 out of 519 | 73rd |
Industry Surgical and Medical Instruments and Apparatus | 88 out of 324 | 73rd |
Source: SEC filing on October 5, 2022.
Sandercock's colleagues
We found three more compensation records of executives who worked with Brett Sandercock at ResMed in 2021.